At a glance
Animal health
doses per day (0.1µg)
per 1,000 doses
protective dose
one standardized R&D workflow
Built for veterinary RNA vaccines
Ultra-high capacity, ultra-low cost, high potency and speed to candidate.
Hover or tap a metric to see the figure.
Fast response and lower cost
Outbreaks don't wait for a bespoke process.
Bring us a disease and we'll bring you a candidate — designed, produced and formulated on one standardized workflow, ready for in-vivo testing, at a manufacturing cost no traditional approach comes close to.
That's the R&D services entry point into N-Force: validate fast, then scale on the same platform.
saRNA / dose
one run
We empower you to unlock the full potential of RNA innovation through diverse collaboration opportunities
In a preclinical poultry challenge study, a saRNA vaccine designed and produced on N-Force achieved 100% survival and 0% viral shedding against highly pathogenic avian influenza (HPAI) Clade 2.3.4.4b — at a protective dose as low as 0.1 µg.
Total manufacturing cost: ~€2 per 1,000 doses, at a production capacity of up to 50 million doses per day on the Ntensify® Midi system.
100 % survival in vaccinated chickens
QCX-CNP: Quantoom’s proprietary delivery technology
GS: Golden Standard delivery technology
100 % shedding protection
% — 2 days post infection
Manufactured for you, or produced in your facility
Start with a proof of concept manufactured by Quantoom, then take design and production in-house when you are ready — on the same N-Force process.
A fast, cost-effective jump onto RNA
Quantoom manufactures preclinical and clinical batches for veterinary development. We put the N-Force toolbox to work to convert your disease into an RNA candidate.
Production at your site
When your program reaches the maturity you want, a technology transfer puts Quantoom's end-to-end workflow on your site. You then design and manufacture under your own control, with full autonomy. Ncode, Ntensify® and Ncapsulate® stay in the process so every RNA-based animal health vaccine follows the same path.